BRISTOL, Tenn., May 3 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc.
(NYSE: KG) reported today that the Company will provide a live webcast of its
conference call to be held following King's announcement of earnings for the
first quarter ending March 31, 2004. As previously announced, King plans to
announce earnings for the first quarter ending March 31, 2004, prior to the
market open on Thursday, May 6, 2004.
Interested persons may listen to the conference call on
Thursday, May 6, 2004, at 1:00 p.m., E.D.T.
at http://www.firstcallevents.com/service/ajwz405006268gf12.html or by dialing
800-795-1259 (US only) or 785-832-1508 (international), passcode KG. If you
are unable to participate during the live webcast, the call will be archived
on King's web site http://www.kingpharm.com for not less than 30 days following the
call. A replay of the conference call will also be available for not less
than 30 days following the call by dialing 888-276-5302 (US only)
or 402-220-2331 (international).
(Minimum requirements to listen to the broadcast: The Windows Media
Player software, downloadable free
from http://www.microsoft.com/windows/windowsmedia/EN/default.asp , and at
least a 28.8 kbps connection to the internet. If you experience problems
listening to the broadcast, send an email to webcastsupport@tfprn.com)
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the first quarter ending March 31, 2004 and
the live webcast of the conference call following the release. These forward-
looking statements involve certain significant risks and uncertainties, and
actual results may differ materially from the forward-looking statements.
Some important factors which may cause results to differ include: dependence
on King's ability to release the Company's financial results for first quarter
ending March 31, 2004, and conduct its conference call as currently planned on
May 6, 2004. Other important factors that may cause actual results to differ
materially from the forward-looking statements are discussed in the "Risk
Factors" section and other sections of King's Form 10-K for the year ended
December 31, 2003 which is on file with the Securities and Exchange
Commission. King does not undertake to publicly update or revise any of its
forward-looking statements even if experience or future changes show that the
indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs of King Pharmaceuticals, Inc., +1-423-989-8125
|
